Trademark: 85324623
Word
DESIGN. OPTIMIZE. DEVELOP.
Status Date
Monday, December 31, 2012
Filing Date
Thursday, May 19, 2011
Published for Opposition
Tuesday, October 4, 2011
Abandoned Date
Monday, December 31, 2012
42 Pharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
Dec 31, 2012
Abandonment Notice Mailed - No Use Statement Filed
Dec 31, 2012
Abandonment - No Use Statement Filed
May 25, 2012
Notice Of Approval Of Extension Request E-Mailed
May 23, 2012
Extension 1 Granted
May 23, 2012
Extension 1 Filed
May 23, 2012
Teas Extension Received
Nov 29, 2011
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2011
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2011
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2011
Published For Opposition
Aug 18, 2011
Approved For Pub - Principal Register
Aug 18, 2011
Assigned To Examiner
May 23, 2011
New Application Office Supplied Data Entered In Tram
May 23, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
